News
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI
- Author:
- Becky McCall
Publish date: March 7, 2025
News
New IL-7 Antagonist Lusvertikimab Shows UC Efficacy
- Author:
- Becky McCall
Publish date: March 4, 2025
News
AI Improves Lesion Detection in IBD Over Standard Methods
- Author:
- Becky McCall
Publish date: March 4, 2025
News
New Biomarkers Identified for Treatment Response in IBD
- Author:
- Becky McCall
Publish date: February 27, 2025
News
Not All Plant-based Diets Are Equal in IBD Risk Mitigation
- Author:
- Becky McCall
Publish date: February 27, 2025
News
Guselkumab Efficacy in Crohn’s Disease Unaffected by Prior Biologic Use
- Author:
- Becky McCall
Publish date: November 5, 2024
News
Patients With IBD More Likely to Develop, or Have Prior, T1D
- Author:
- Becky McCall
Publish date: November 5, 2024
News
Ultraprocessed Foods Associated With Relapse Risk in Crohn’s Disease
- Author:
- Becky McCall
Publish date: October 30, 2024
News
Cendakimab That Targets IL-13 Shows Promise in Eosinophilic Esophagitis
- Author:
- Becky McCall
Publish date: October 29, 2024
News
When It Comes to Polyp Diagnosis With CADx, Location Matters
- Author:
- Becky McCall
Publish date: October 29, 2024
News

Exocrine Pancreatic Insufficiency: Optimal PERT Dose Varies by Primary Pancreatic Disease
- Author:
- Becky McCall
Publish date: October 18, 2024
News
Type 2 Diabetes: Insulin-Free for 24 Months After Novel Endoscopic Procedure
- Author:
- Becky McCall
Publish date: October 15, 2024
News
GPs Urged to Embed Lifestyle Medicine into Primary Care
- Author:
- Becky McCall
Publish date: October 14, 2024
News
New Guidelines Emphasize Liver Care in T2D, Obesity
- Author:
- Becky McCall
Publish date: October 2, 2024
News
‘Remarkable’ Weight Loss Seen With Safe, Tolerable Novel Oral Combination
- Author:
- Becky McCall
Publish date: September 13, 2024